StockNews.AI
TVTX
StockNews.AI
117 days

Travere Therapeutics to Report First Quarter 2025 Financial Results

1. Travere Therapeutics will report Q1 2025 financial results on May 1. 2. A conference call will follow to discuss results and business updates.

2m saved
Insight
Article

FAQ

Why Neutral?

Routine earnings reports typically have unpredictable impacts; no significant surprises anticipated based on previous trends.

How important is it?

Earnings reports generally affect stock pricing, but upcoming dates provide lesser immediate relevance without context.

Why Short Term?

Immediate effect seen in stock price post-earnings report, but long-term implications depend on results.

Related Companies

NASDAQ: AMLXNASDAQ: MNKDNASDAQ: TGTX
SAN DIEGO--(BUSINESS WIRE)-- #1Q25Earnings--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. The webcast and dial-in information can be accessed on the Investor page of Travere's website at https://ir.travere.com/events-and-presentations. Fo.

Related News